publication . Article . Other literature type . 2016

Blood-Based Biomarkers for Metabolic Syndrome

O'Neill S; Bohl M; Gregersen S; Hermansen K; Lorraine O'Driscoll;
Restricted English
  • Published: 01 Jun 2016
<p>Metabolic syndrome (MetS) is a constellation of factors increasing the risk of type 2 diabetes mellitus (T2DM), cardiovascular disease (CVD), and cancer. MetS diagnosis is cumbersome and the precise diagnosis differs throughout the world. Efforts are underway to find MetS biomarkers that could all be analysed in a single blood sample. Here we review recent advances, including progress on circulating exosomes and microvesicles and their molecular contents, as well as DNA, RNAs, and proteins taken directly from blood samples. While additional research is now warranted to advance upon these findings, there is reason for optimising that such blood-based entities ...
free text keywords: Disease, Microvesicles, Bioinformatics, Type 2 Diabetes Mellitus, Metabolic syndrome, medicine.disease, medicine, Biomarker (medicine), Cancer, Additional research, Diabetes mellitus, business.industry, business
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue